Toronto, ON, June 28, 2021 (GLOBE NEWSWIRE) -- Thomson Rogers and Rice Harbut Elliott LLP have jointly issued a national class action on behalf of all persons in Canada who used a Philips CPAP machine, BIPAP machine or mechanical ventilator which are currently subject to a recall by the company.
On June 14, 2021, Philips Respironics issued a recall notice in the US for approximately 35 models of its Respiratory Devices that were manufactured with a Polyester-Based Polyurethane (PE-PUR) sound abatement foam. Exposure to the PE-PUR foam can have adverse health effects including, but not limited to, increased cancer risk, respiratory damage, asthma, nausea, vomiting, and headache.
As of June 23, 2021, Health Canada recalled all of the subject Respiratory Devices.
It is alleged that Philips Respironics negligently designed and manufactured the Respiratory Devices and failed to warn users of the health risks associated with use of the Respiratory Devices, while assuring users of the safety of its products.
The Representative Plaintiff, John Morel, was diagnosed with sleep apnea and purchased a Philips Dreamstation CPAP machine in 2019. Commenting on learning about the health risks associated with the machine, he states:
"I was horrified to learn that my CPAP machine, which blows air into my lungs, could contain toxic particles. I relied on this device to treat my sleep apnea and I am concerned for my health. I have questions about when Philips became aware of the issue and if this could have been disclosed earlier."
For further information regarding this claim, please contact:
Stephen Birman at Thomson Rogers (sbirman@thomsonrogers.com or 416-868-3137); or
Robert Ben at Thomson Rogers (rben@thomsonrogers.com or 416-868-3168); or
Lucy Jackson at Thomson, Rogers (ljackson@thomsonrogers.com or 416-868-3154); or
Anthony Leoni at Rice Harbut Elliott LLP (aleoni@rhelaw.com or 604-682-3771); or
Jaclyn Vanstone at Rice Harbut Elliott LLP (jvanstone@rhelaw.com or 604-682-3771).